Etoposide Market: Approaching Demand & Growth Prospect 2024
Etoposide is a derivative of epipodophyllotoxins that are derived from Mandragora officianarum (plant). Its chemical name is 4'-demethyl-epipodophylotoxin 9-[4,6-O-(R)-ethylidene-?-D-glucopyranoside] and it was introduced in the market in 1970. Currently, it is utilized extensively in manufacturing drugs that help treat various human malignant diseases such as testicular cancer, lymphomas (Hodgkin, non-Hodgkin), leukemia and lung cancer. Other diseases that are treated by consumption of etoposide include Ewing sarcoma, Kaposi disease, rhabdomyosarcoma, soft tissue sarcoma, pediatric brain tumors, gastric cancer, Wilms tumor, multiple...
View full press release